IQAIF (Imaging Biometrics) Total Stockholders Equity: $0.41 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Imaging Biometrics Total Stockholders Equity?

Imaging Biometrics IQAIF Total Stockholders Equity is $0.41 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

Imaging Biometrics's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $0.41 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Imaging Biometrics's Book Value per Share for the quarter that ended in Jun. 2026 was $0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Imaging Biometrics's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.58.


Imaging Biometrics  (OTCPK:IQAIF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Imaging Biometrics's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Imaging Biometrics's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imaging Biometrics Total Stockholders Equity Related Terms


Imaging Biometrics Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Imaging Biometrics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imaging Biometrics Total Stockholders Equity Chart

Imaging Biometrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 0.85 0.12 0.38 0.32

Imaging Biometrics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.38 0.70 0.32 0.41
What does a Total Stockholders Equity of $0.41 Mil mean?
Imaging Biometrics (IQAIF) has a Total Stockholders Equity of $0.41 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Imaging Biometrics and its competitors.
Is Imaging Biometrics' Total Stockholders Equity too high?
Imaging Biometrics' current Total Stockholders Equity is $0.41 Mil.
How does Imaging Biometrics' Total Stockholders Equity compare to VEEV and BTSG?
Imaging Biometrics' Total Stockholders Equity of $0.41 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Imaging Biometrics and its competitors. Imaging Biometrics's current Total Stockholders Equity is $0.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current Total Stockholders Equity of $0.41 Mil. The current Total Stockholders Equity is $0.41 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current Total Stockholders Equity is $0.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imaging Biometrics Business Description

Other Exchanges IBAI:UK
Address IFC 5, Channel Islands, Saint Helier, JEY, JE1 1ST
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.